Latest Placebos news
Open-Label Placebo Plus Treatment Rationale Effective for PMS
posted March 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Open-Label Placebo May Reduce Fatigue in Cancer Survivors
posted February 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Open-label placebo may reduce fatigue in cancer survivors, according to a study published online Feb. 9 in Scientific Reports.
Open-Label Placebo Treatments Can Ease Chronic Low Back Pain
posted October 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Patients who knowingly took a placebo pill while undergoing traditional treatment for lower back pain had less pain and disability than those who received traditional treatment alone, according to a study published online Oct. 13 in Pain.
Branded Rx May Up the Power of Placebo
posted November 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
A brand-name label made a placebo tablet work as well as an active nonsteroidal anti-inflammatory drug, according to research published online Oct. 12 in Health Psychology.
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus Monthly Specialist Briefings
Stay Connected
